CVS Health Corp. Hits New 52-Week High at $104.93

CVS Health Corp. has reached a significant milestone by hitting a new 52-week high of USD 104.93 on June 25, 2026. This achievement underscores the company's strong performance in the retailing sector, particularly as it has demonstrated a remarkable 73.62% increase over the past year, significantly outperforming the S&P 500, which has risen by 20.77% during the same period. With a market capitalization of USD 118,730 million, CVS Health Corp. is classified as a large-cap company. The stock's price-to-earnings (P/E) ratio stands at 13.00, indicating a favorable valuation relative to its earnings. Additionally, the company offers a dividend yield of 2.83%, appealing to income-focused investors. CVS Health Corp. maintains a debt-to-equity ratio of 0.72, reflecting a balanced approach to leveraging, while its return on equity is reported at 12.13%, showcasing effective management of shareholder equity. The stock's previous 52-week low was recorded at USD 58.50, highlighting the significant upward movement in its price.